Veterinary nurses, veterinary surgeons, students and other veterinary professionals are all invited to take part in the anonymous survey and share incidents where they have witnessed discrimination or felt discriminated against.
The survey covers the nine protected characteristics under the Equality Act: age, gender reassignment, marital or partnership status, being pregnant, disability, race, religion, sex and sexual orientation. It also includes other forms of discrimination which might not fit under these characteristics, such as body weight and socio-economic background.
BVA Junior Vice President Daniella Dos Santos said: "The veterinary professions should be open, welcoming and supportive of everyone; however, it is clear from the reports we’re hearing that discrimination is still an issue. Worse still, we’re aware that some colleagues have faced a backlash when talking about their experiences of discrimination. This is completely unacceptable.
"If we hope to prompt meaningful change we need to fully understand the scale of the problems our colleagues are facing. To do that it’s important that we provide a safe, anonymous space for everyone to share their experiences. We hope this questionnaire will give people that opportunity and we would like to sincerely thank our colleagues for their willingness to share their personal experiences with us."
The survey was developed with the support of the British Veterinary Ethnicity and Diversity Society (BVEDS) and British Veterinary LGBT+.
BVA says it intends to gather further quantitative data on discrimination via its Spring Voice of the Veterinary Profession Survey 2019.
The questionnaire is open from 2 February until 2 March and should take around 10 minutes to complete. A link to the questionnaire is available here.
The winners and runners up will be honoured at a ceremony taking place on the eve of BSAVA Congress on 1st April 2020.
The television presenter Matt Baker will be hosting the Ceva Animal Welfare Awards for the third consecutive year, alongside head judge Chris Laurence MBE FRCVS, who puts his name to the Vet of the Year Award.
The award categories include:
Chris Laurence Vet of the Year – sponsored by Vet Record
Vet Nurse of the Year – sponsored by Agria Pet Insurance
Charity Team of the Year – sponsored by PDSA
Charitable Contribution of the Year – sponsored by Blue Cross
International Cat Care Welfare of the Year – sponsored by International Cat Care
Farmer of the Year – sponsored by R.A.B.I. and Farmers Guardian
Farm Educator of the Year – sponsored by NADIS and Farmers Guardian
Outstanding Contribution to Animal Welfare – sponsored by Your Dog and Your Cat magazines
To nominate someone, visit wwww.cevawelfare.com. They can come from all walks of life and will be assessed on the evidence provided in the original nomination.
Entries must be in by Tuesday 31 December 2019.
Ceva Animal health has launched Marbox, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. According to the company, Marbox effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.
Ceva says mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.
Marbox is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.
Marbox can be used in combination with Meloxidyl, Ceva's new, single shot anti-inflammatory. The product joins Ceva's bovine range of anti-infectives, which includes Cevaxel, Florkem and Spectam Injectable.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from former Wirral-based vet Ian Beveridge.
In May 2013 the Committee had asked the Registrar to remove Mr Beveridge from the Register following a four-day hearing in which he was found guilty of serious professional misconduct after finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the RCVS and that animals in his care were placed at risk.
In June 2013 Mr Beveridge, who was not present or represented at the original hearing, then appealed the decision. The appeal was withdrawn in May 2014 which was when Mr Beveridge was formally removed from the Register.
Then, in April 2015, Mr Beveridge applied to be restored to the Register. The Disciplinary Committee met to consider his application in June 2015, however, this hearing was adjourned after new evidence was served to the Committee concerning allegations that Mr Beveridge had ordered prescription-only veterinary medicines when he was not authorised to do so. He was subsequently interviewed by police who took no further action.
In deciding whether Mr Beveridge was fit to be restored to the Register, the Committee heard evidence in regards to the circumstances in which the prescription-only drugs were ordered using his account and delivered to his former practice address which had been taken over by Medivet after he sold the premises to the company.
During the course of the hearing, Mr Beveridge admitted that his account had been used to buy the drugs, but that a part-time member of his staff, who was neither a veterinary surgeon nor a veterinary nurse, had done so without his prior knowledge or approval.
In relation to this evidence Ian Green, chairing and speaking on behalf of the Committee, said: "The Committee takes the view that the unauthorised use of a veterinary surgeon’s drugs account for which he carries the ultimate responsibility is a very serious matter and, of itself, demonstrates that the applicant has at best a cavalier attitude to his work which of itself means that he remains unfit to be on the Register.
"This attitude is further demonstrated by the fact that, even after the first orders were placed in late April and early May 2014, the applicant did not seek clarification from the College of his status following the withdrawal of his appeal against the original Committee’s findings."
In addition to this, the Committee also considered the seriousness of his original failings, the fact that Mr Beveridge’s acceptance of these failings was ‘qualified’, that he had been off the Register for 20 months and the fact that his efforts in terms of continuing professional development had been inadequate and not focused on those areas in need of improvement, among other factors. In mitigation it did consider that Mr Beveridge had demonstrated genuine remorse about previous actions and noted a petition and a large number of letters in support of him from former clients of his practice.
However, the Committee felt that this did not detract from the seriousness of the original failings and, in conjunction with the subsequent unauthorised ordering of veterinary drugs, that the application for restoration must be dismissed.
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
Improve Veterinary Education will maintain its core mission and quality promise: to deliver all postgraduate training and education programmes for vets and vet nurses through face to face, online learning, blended learning and short course options.
Improve Veterinary Practice offers an online knowledge hub so veterinary professionals can access the latest advice, news and information across all specialties.
Membership also offers ways to keep track of and meet your annual CPD targets.
ISVPS assesses our training programmes and awards globally recognised postgraduate veterinary qualifications to both vets and vet nurses in a range of clinical subjects.
Katie Hungerford, Director of Marketing at Improve International Group, said: “We have modernised all aspects of the Improve International Group to reflect our movement towards providing more online and blended learning choices.
"The experience for veterinary professionals will now feel coherent with simplified graphics and information, no matter which part of the business they need to use.”
A survey carried out by Fish4Dogs has found that a 'staggering' 43% of dog owners do not brush their dog's teeth.
As part of the research, 800 people from across the UK were quizzed about their attitude to their pet's dental care in the lead up to the British Dental Health Foundation's 'National Smile Month' (May 20th-June 20th).
The survey also found that:
Graham Smith, Chief Executive of Fish4Dogs said: "This research is definitely an interesting read about people's attitudes and behaviours towards dental care for their dogs. National Smile Month campaigns for healthy and happy teeth and there is no reason this shouldn't apply to our pets too. At Fish4Dogs we have never doubted how important dogs are to their owners, but it is clear that with wider awareness we could encourage teeth brushing to become more regular and an introduction of dry food into dogs' diets and all see improved results."
The charity says that the survey is the largest, most comprehensive insight into pet wellbeing in the UK; an opportunity for veterinary professionals to share their views on the issues affecting the health and welfare of UK pets today.
Vicki Betton, PDSA Policy and Campaigns manager, said: "For the last five years, the PAW Report has provided valuable insight into the reality of pet health and wellbeing in the UK.
"It delivers a robust evidence base for our education programmes, campaigns and collaborative work, and enables us to track our impact on the pet wellbeing issues which are of most concern to the veterinary profession. It also provides an excellent opportunity for everyone to voice their opinions and have their say.
"In 2015, two of the main concerns identified were lack of public understanding of the cost of pet ownership, and a lack of pre-purchase education relating to suitable pet choice. This was reinforced in our survey of pet owners, in which over 95% of pet owners incorrectly estimated the lifetime costs for their pet. As a result, we launched our #PawsFirst campaign to engage pet owners about how to choose the right pet for their lifestyle, while raising awareness of the lifetime costs of different species."
The current survey closes on 4 July. Vicki added: "It only takes 15 minutes, so please help us maintain an accurate picture of the biggest welfare issues facing pets in the UK today."
Take the survey at www.yougov.com/PDSA and help spread the word by sharing on social media - #PAWreport
Animalcare has announced the launch of Identichip Ultra, a new slimline microchip with enhanced read range for smaller species
The new microchip is 1.4mm wide and is inserted with a 15 gauge needle which is 50% slimmer than the needle used with standard microchips. The length of the mini microchip has been increased to 10.3mm to accommodate a longer ferrite rod which boosts the signal to the microchip scanner.
Animalcare says Identichip Ultra has been designed to offer a slimline microchipping solution for small species and breeds with a reduced compromise on read range.
Beverley Campbell, Identichip and Anibase Product Manager said: “We recognised the increasing trend for slimmer microchips and the benefit this offers for small species and breeds. We also know that mini microchips have a reduced read range which could ultimately lead to a microchip not being detected so we wanted to challenge this and bring a solution to the market.
"Identichip Ultra is as slim as the other mini microchips currently being offered but the increased length gives us a read range up to 24% further1. We firmly believe that there is a place for mini microchips in the market and while we have enhanced the read range versus other mini brands we still believe that standard size microchips should be used in larger animals. We would encourage implanters to always choose a microchip size suitable for that particular animal in relation to its size now and when fully grown.”
With compulsory microchipping of dogs due to be introduced in England, Scotland and Wales from April 2016 awareness of microchipping is increasing. However, Animalcare says it still feels there is a lot of education needed to ensure dog owners are prepared for the legislation. For this reason, it has produced a range of promotional materials including leaflets, posters, letter templates and digital stickers.
Identichip Ultra is available in a sterile packed syringe style implanter with a detachable needle for sharps disposal.
For further information speak to your Animalcare Representative.
1Based on a laboratory trial comparing mini microchips (1.4mm x 8.5mm), standard microchips (2.1mm x 12.5mm) and idENTICHIP Ultra (1.4mm x 10.3mm) using three different microchips scanners (RT100-V5, Halo Scanner and idENTICHIP Pocket Reader)
The British Veterinary Association has announced the results of the Voice of the Veterinary Profession survey, which found that 84% of veterinary surgeons give up time to work with animal charities and shelters.
72% have a formal arrangement with charities to provide their time and veterinary expertise at a reduced rate, while more than 43% work completely unpaid for animal charities and shelters; treating thousands of abandoned, mistreated or injured animals each year.
The charitable work undertaken by practitioners varied from practice to practice, but included:
On top of all that, veterinary surgeons also provide emergency treatment for stray and wild animals brought in by the public. Although they will sometimes receive a charitable donation towards the cost of treatment through schemes like the RSPCA Initial Emergency Treatment (IET) Scheme, that is by no means always the case.
RSPCA Chief Veterinary Officer James Yeates said: "Vets’ work in this area can go unrecognised but it is appreciated by the RSPCA that they are part of the team trying to help animals. The RSPCA is dedicated to helping animals most in need and relies on vets’ welfare work to help bring a stop to the suffering of all animals."
BVA President Sean Wensley, said: "Behind these statistics are countless stories of veterinary teams – who already often work long, demanding hours – giving their time for free to support animal rescue staff and charities to care for abandoned, injured and neglected animals, as well as help owners to keep and care for much loved animals in times of hardship and crisis. The UK’s network of animal charities and rehoming centres do a fantastic job protecting wild and domestic animals each year. Animal welfare legislation is clear that animal keepers and owners are responsible for meeting their animals’ needs, and prospective animal owners must be aware of the cost and time commitment involved in animal ownership, but we appreciate people’s circumstances can change."
Photo: Javier Brosch/Shutterstock
Titled ‘The Five Steps of Seizure Management’, the sessions will update veterinary surgeons and nurses on:
Will Peel, Product Manager at TVM UK said: "The Lunch and Learn sessions have proved very popular with veterinary practices. Our aim is to update vets and nurses on diagnosis and management of epilepsy in general practice whilst educating them about products and services which can help them better support their patients."
TVM says it will also provided supporting literature, including guidelines and owner educational tools, designed to help veterinary staff in diagnosing and treating pets with epilepsy.
To book a Lunch and Learn, contact your local TVM UK territory manager or email help@tvm-uk.com.
The new guide, developed in association with Vets Digital, is the latest addition to BVA’s ‘Respect your vet team – end abuse’ campaign, which aims to support vets and veterinary workplaces who experience abuse from animal owners either in person or online.
It will be added to the Respect Your Vet Team toolkit, which offers a range of resources designed to help protect staff and limit the frequency and impact of abuse from clients.
The resources include practical tips on how to protect staff from online abuse, downloadable posters encouraging respectful behaviour from clients and a series of blogs exploring the issues.
BVA President Malcolm Morley said: “The vast majority of clients are hugely appreciative of the care they receive from their vet teams, resulting in thousands of positive reviews every year.
"While we recognise not every client will have a positive experience and may wish to provide critical feedback, a small number are posting deliberately abusive or unfair reviews.
"This is unacceptable and can have a hugely negative impact on individual veterinary professionals and the wider team.
"Protecting the wellbeing of veterinary teams remains a top priority for BVA and this new resource will help vet teams to take practical steps to limit the impact of this type of abuse.”
https://www.bva.co.uk/resources-support/misc-resources/how-to-manage-unfair-and-abusive-reviews-online
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
BEVA President, Madeleine Campbell will be announcing plans for a veterinary-led European Transport Forum at BEVA Congress this year (8-11 September 2010), to discuss how the welfare of horses during transport can be improved through the better enforcement of legislation.
Dr Campbell is also the British Veterinary Association representative on the Federation of Veterinarians of Europe (FVE) working party for transport. The Forum, which will be held in Brussels on 29 November 2010, has been jointly organised by the FVE and BEVA and is sponsored by World Horse Welfare (WHW). It is hoped that it will be attended by over 150 participants, including representatives of EU Member States, CVOs, Members of the European Commission and European Parliament, scientific experts, national veterinary organisations, animal transport associations and animal welfare associations.
The Forum will review the enforcement of the existing European regulations that currently govern the transport of horses for slaughter and for other purposes. Areas for practical improvement will be identified with the key focus on the enforcement of current legislation and the role of vets in ensuring that the welfare of horses in transit is protected. The conference will endeavour to define the critical control points, effective control systems and good practices. It will also look into trade flows, animal health risks, horse identification and the effects of closing horse slaughterhouses.
Dr Campbell said: "It is all very well to campaign for new regulations but at present even the existing regulations are not being enforced adequately. The crux of the matter is enforcement and there are none better placed to help with this than vets. If we can all work collectively we should have the strength to make a real impact. This is what the Forum is about."
Dr Campbell will be speaking about the European Transport Forum at the Congress press conference on 10 September between 9am and 10am.
BEVA Congress runs from 8-11 September 2010 at the International Convention Centre, Birmingham. For further information and to register visit http://www.beva.org.uk/
Seven graduands from The University of Nottingham's School of Veterinary Medicine and Science have become the first from the new school to become members of the Royal College of Veterinary Surgeons.
Nottingham is the first new veterinary school in the UK for over 50 years, and the process to recognise its degree for the purposes of RCVS membership is currently in its final stages. Following a visitation and audit process, RCVS Council unanimously recommended the degree's approval to the Privy Council, where the final decision lies.
Generally, veterinary graduates become RCVS members - which they need to be in order to practise in the UK - at a ceremony on the day of their graduation. However, sometimes they wish to start work before graduation and can therefore apply to register as graduands, as in this case.
Although formal Privy Council approval of the Nottingham degree is still awaited, RCVS external examiners have overseen the School's final exams during the last year of the course to ensure that they meet the required standards.
The Nottingham graduation ceremony will take place on 22 July, when a further 77 students will graduate, and those wishing to practise in the UK will become members of the College.
The RCVS 2010 Survey of the Veterinary and Veterinary Nursing Professions indicated that, on average, new graduates took one month to find work on graduating, with 63% going straight into clinical practice.
The study, which examined cattle farmers’ and veterinary surgeons' opinions of pain-induced distress associated with disbudding, analgesia and attitudes and the use of non-steroidal anti-inflammatory drugs (NSAIDs), suggests that in particular, vets need to refine their understanding of farmers’ priorities, and how they guide clients on methods to improve calf welfare.
There have been a number of studies into the pain-induced distress resulting from the disbudding procedure. All methods of disbudding (apart from chemical cauterisation) in the UK require the use of a corneal nerve local anaesthetic blockade but there are currently no legislative requirements for the use of NSAIDs for disbudding – it is at the discretion of the farmer or veterinary surgeon carrying out the procedure. NSAIDs are routinely used in companion animals and equine practice, but less so in farm animals.
This new study, conducted by researchers at the Royal Veterinary College (RVC) in Hertfordshire and Aran Vet Clinic in Gwynedd, looked at the attitudes of farmers and vets on pain perception and pain management methods for disbudding. A total of 118 vets and 140 farmers contributed to the study. Of the respondents:
The study concluded that veterinary surgeons underestimate the influences of welfare and analgesic duration and effectiveness on farmers' decisions, and overrated cost impact. This perception could have a negative effect on veterinary recommendation.
The authors of the study therefore advise that steps should be taken to address the current inadequacies in the communications between vets and clients in conveying the practicalities and potential benefits of using NSAIDs.
Dr Troy Gibson, PhD, PGDipSci, BSc, Lecturer in Animal Welfare Science at the Royal Veterinary College said: "Despite the large amount of evidence of the benefits of NSAIDs for disbudding, it is disappointing that their use is still not widespread. This may partly be due to the only recent licencing of one NSAID for cattle. However, from our work it is clear that one of the key barriers to wider uptake is the breakdown in communication between veterinarians and their clients in conveying the cost, practicalities and potential benefits of NSAID use for disbudding. The wider use of NSAIDs in combination with local anaesthetics during disbudding would significantly improve calf welfare."
Reference
Humanimal Trust is the only organisation in the UK with the sole purpose of progressing One Medicine, driving collaboration between vets, doctors, nurses and researchers so advances in both human and animal medicine can be achieved faster.
The seminar, entitled One Medicine in Action – Awareness, Collaboration and Change, follows on from the Trust’s inaugural symposium last year when a roadmap was created on how to develop closer links between human and veterinary medical and research professionals.
This year’s event will look at ways to put the roadmap into action through awareness raising, increased collaboration and change.
Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust (pictured right), said “We know that when animal and human health professionals and scientists come together, great things happen.
"Last year’s symposium, which was part of our ‘Stronger Together’ campaign, was a huge success.
"It drew an audience from across the UK and Europe, as well as Chile, the United States, Singapore and Australia.
“Not only did it provide a real opportunity to explore ways to achieve more ethical and fair medical progress for all, but it also allowed connections to be made and relationships to be forged that wouldn’t otherwise exist.”
Miss Anna Radford, a Consultant in Paediatric Surgery at Hull University NHS Trust and Leeds Children’s Hospital, who is speaking at the seminar in May, said: “I was introduced to a diagnostics company working in the animal medical care field at last year’s symposium and through them, we have set up a new collaboration with the aim of determining whether this sort of diagnostic technology developed with companion animal medicine in mind, could potentially also be useful to help diagnose urinary, joint and cerebrospinal fluid infections in a busy NHS hospital setting.”
Other speakers at this year’s event include Dr Deborah Thomson, Founder and President of One Health Lessons, an organisation that inspires children and adults around the world to value the interconnection between human health and the health of the environment, plants and animals.
Dr Simon Doherty, a Senior Lecturer at the Institute of Global Food Security at Queen’s University in Belfast will highlight organisations that are successfully working together to improve the sustainability of dairy, meat and fish production to feed a growing global population, as well as the opportunities that exist for collaboration within the agri-food sector.
Dr Doug Brown, CEO of the British Society for Immunology, will share some of the most notable examples of joined-up approaches in human and animal health research from across the Society’s membership, with a particular focus on veterinary immunology.
The seminar, which will run from 2pm until 5.15pm BST, will end with a panel Q&A session, chaired by Humanimal Trust Trustee and Consultant Respiratory Physician at the University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall.
Attendance is free and registration is now open to all human and veterinary medical professionals and students, and the allied health and scientific disciplines.
To find out more and register, visit www.humanimaltrust.org.uk
Vetoquinol has introduced a new smaller pack size for Reprocine, to help prevent wastage. The new 6 x 10ml pack is now available from wholesalers.
Reprocine is licensed in the cow for uterine atony during the puerperal (post-parturient) period, placental retention as a consequence of uterine atony and initiation of milk ejection in a stress-induced agalactia or in conditions requiring udder emptying. In the sow, Reprocine is licensed for uterine atony during the puerperal period also, supportive therapy of mastitis-metritis-agalactia (MMA) syndrome, initiation of milk ejection and for shortening of parturition period. Reprocine is an intraveneous or intramuscular injection and has the added advantage of no milk or meat withdrawal.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "The new pack size reduces wastage which provides an instant cost-effective advantage.
"Reprocine is rapidly distributed and slowly eliminated. Efficient parturition and milk ejection is essential for newborn welfare and ultimately provides an economic benefit. Reprocine can be utilised in many reproductive associated conditions."
Reprocine is also available in 50ml bottles.
Avishield IB G1-13 is indicated for active immunisation of chicks to reduce the adverse effect on cilia caused by infectious bronchitis.
The vaccine is one of two targeting the IBV 793B serotype and, with the addition of this new claim, Avishield can now be administrated on broiler, broiler breeder and laying hen farms.
Avishield IB GI-13 is a lyophilisate for oculonasal suspension/use in drinking water which contains live avian infectious bronchitis virus variant strain V-173/11: 102.7-104.6 EID50.
It has an onset of immunity 10 days after vaccination and a duration of immunity of 56 days.
Johnny Wells West, poultry key account manager at Dechra Veterinary Products, said: “The new licence extension for Avishield IB G1-13 allows greater flexibility for poultry producers to protect their flocks against infectious bronchitis on broiler, broiler breeder and laying hen farms and it is welcome news for both Dechra and the poultry industry.”
For more information contact Johnny Wells West on 07584 175758 or visit http://www.dechra.co.uk/Avishield IB G1-13
The survey of 2067 past or present adult dog owners, of which 1,170 had experienced the loss of a dog, also found that about half had experienced barriers to opening up about their feelings following the death of their pet.
Some of the reasons given for not opening up included believing others wouldn’t understand their feelings (22%), fear of being judged for being upset (15%), feeling embarrassed about their levels of distress (12%) and not being able to find the right words to describe their feelings (13%).
74% felt they could turn to close family to share feelings of grief over the loss of the dog, but only 13% felt they could discuss it with employers and colleagues.
Samantha Davis, Legacy and In-Memory Manager at Dogs Trust, says: “The loss of a pet dog can be as devastating as losing a family member.
"Dogs hold a special place in our hearts, offering unconditional love and companionship, and when they pass away, the grief can be profound and, sadly for some, isolating.
“It's really important that owners who experience the loss of their canine companions can open up and share their feelings with friends and family.
"Many will find solace in knowing they are not alone."
To support people who have lost a dog, Dogs Trust is holding a 3.5km walk to bring people together to share their memories of their beloved animal.
Walk for Our Old Friends (WOOF) will take place in Salcey Forest, Northampton, on Sunday 6th October 2024 between 4pm-7pm.
As walkers make their way through the forest, there will be opportunities for moments of remembrance and celebration.
The charity will also provide support resources for those participating with a team onsite as well as online information to help people cope with their loss.
Dogs Trust is also providing online resources for people to organise their own walk in memory of their much missed four legged friends.
https://events.dogstrust.org.uk/event/walk-for-our-old-friends
COMMENT
Was this survey desperately flawed, or has our relationship with our dogs become unhealthily anthropomorphic?
It's hard to think of any other explanation for why such large proportion of people equate the death of a dog with the death of a brother, sister, parent or child.
Surely the death of a close family member is in an altogether different league than the death of even the most beloved dog.
If people are developing unhealthily close relationships with their animals, the question is why?
Are they being pushed by commercial interests which encourage people to think of themselves as 'pet parents' in order that they feel compelled to spend more on their 'child'.
Or is there some other factor in play?
Does it matter anyway?
Perhaps not.
But more and more we hear stories of people saddling themselves with crippling levels of debt on treatment because they cannot face the inevitable.
Perhaps it is time to return to a more healthy, more matter-of-fact relationship with our pets.
No less loving, just tempered by the acceptance of the fact that it is not human. It's a dog.
The British Veterinary Association has announced that it has almost halved the cost of attending its annual Congress this September.
According to the BVA, the decision was made to demonstrate its commitment to providing high-quality, affordable CPD.
The two-day event will now cost £150 +VAT for members and £300 +VAT for non-members for up to 11 hours of small animal CPD provided by the University of Liverpool.
The choice of topics includes:
The BVA says all the lectures will be delivered by leading experts in their field.
Alongside the clinical CPD programme BVA will run its contentious issues stream with discussions around the impact of women on the profession, horses for sport and the use of antimicrobials.
BVA Past President and small animal vet Harvey Locke worked with the University of Liverpool to create the clinical CPD programme. He said: "With a small animal clinical programme provided by the University of Liverpool, the BVA this year not only provides world-class CPD at Congress but it also comes at a fantastic price.
"BVA is committed to providing high-quality CPD to our members at affordable rates. We look forward to welcoming vets to Liverpool in September for our great value CPD programme."
BVA Congress takes place in Liverpool on 27-29 September at the Merseyside Maritime Museum.
The full programme and further information is available at www.bva.co.uk/congress.
The company says it has been working hard to ensure improved supply on a number of brands including Apoquel, Palladia and now Trocoxil, with animal welfare being the key consideration at all times throughout this process.
Ned Flaxman, business unit director for companion animal, equine and innovation at Zoetis said: “It was a really difficult decision to stop production of Trocoxil in favour of Apoquel and Palladia but we felt that it was the right thing to do on animal welfare grounds. As soon as we had full stocks of these products we resumed the manufacture of Trocoxil and I am delighted to say that it will be back in stock in December.
"I would like to thank our veterinary clients for their patience and reassure them that we brought the product back to market as quickly as we could and do not anticipate any further stock issues."
Trocoxil chewable tablets are used for the treatment of pain and inflammation associated with degenerative joint disease in dogs aged 12 months or over.
For more information, contact your Zoetis account manager.
It seems that a series of one day conferences, organised by the Animal Health agency for vets and animal health inspectors involved in fighting bovine TB, haven't gone down as well as hoped.
According to a report in yesterday's Daily Telegraph, many in the audience were angered when they were asked to spend up to an hour playing a game involving bongo drums.
Incredibly, a spokesman for Animal Health apparently told the Daily Telegraph that: "It was meant to emphasise how people working together can build up a rhythm."
Ceva Animal Health has launched Cystease Advanced, a new urinary tract support supplement for cats.
The new product, which contains N-acetyl glucosamine, L-tryptophan and Hyaluronic Acid, is described as an elaboration on the original product, Cystease S.
Ceva says Cystease Advanced has been designed to help support the bladder lining while also reducing stress-related behaviour in cats.
Fraser Broadfoot, small animal product manager at Ceva Animal Health, said: "It is well documented that stress can adversely affect the integrity of the bladder lining. There are many factors that cause stress in cats, for example inter-cat conflict, moving house, new arrivals to the home environment and car travel, to name just a few.
"Our new product has been developed to address both conditions; it contains N-acetyl glucosamine and Hyaluronic Acid which are key components of the GAG lining, whereas L-tryptophan has been proven to reduce stress-related behaviour in cats."
Cystease Advanced is taken orally and is available in pots of 30 and 300 tablets.
Ceva recommends that Cystease Advanced is used with Feliway, the company's appeasing pheromone for cats.
For further details please contact the customer support team on 01494 781510.
Animalcare Ltd has launched Marbocare (marbofloxacin) 100mg/ml solution for injection, a third-generation fluoroquinolone for the treatment of E.coli mastitis and bovine respiratory disease (BRD) in cattle, and Metritis Mastitis Agalactia in pigs.
The company highlights the product's unique flexible dosage regimen of once daily injections for 3 days against E.coli mastitis and BRD, plus a single intramuscular (IM) high dose (8mg/100kg) for BRD.
Animalcare says this regimen, coupled with the flexibility of administration afforded by all three injection routes (intravenous IV, subcutaneous SC and IM), a low volume dose and good syringeability, all combine to offer ease of use; resulting in a reduction in handling and less stress for the cattle.
Developed for veterinary use only, Marbocare has broad spectrum activity against Gram+ve and Gram-ve pathogens. Animalcare says the product is especially effective against E.coli mastitis and the key bacterial pathogens associated with BRD, as well as M.bovis.
Marbocare has milk withdrawal times of 36 hours after the last treatment following the 3 day course and 72 hours after a single shot for BRD. Meat withdrawal is 6 days after multiple injections and 3 days after the single shot.
Marbofloxacin has proven efficacy in a comparative international, multi-centre, controlled, randomised field trial1 in 62 dairy cows with E.coli mastitis. Marbofloxacin cure rates were significantly higher than the control product. In respiratory disease it showed a more rapid clinical response in comparison to tilmicosin2, ceftiofur3 and oxytetracycline4. Marbofloxacin was shown to be well tolerated, leading to a fast return to appetite, liveweight gain and associated welfare benefits.
Marbocare is also licensed in the treatment of Metritis Mastitis Agalactia syndrome in pigs, given by IM injection, with a 4 day meat withdrawal.
Tony Liepman, Product Manager from Animalcare said: "Marbocare is competitively priced whether used on its own or alongside a single-dose anti-inflammatory such as Emdocam (meloxicam)."
Marbocare is a POM-V licensed product presented in 50 and 100ml multi-dose vials.
References